DIRTT Environmental has a 37% upside, says Laurentian

Ahead of second quarter financials from customized interior environments company DIRTT Environmental Solutions (DIRTT Environmental Solutions News, Stock Quote, Chart TSX:DRT), analyst Elizabeth Johnston of Laurentian Bank Securities is maintaining her “Buy” rating and $10.00 target price, which translated into a projected return of 37.0 per cent at the time of publication.

Calgary-based DIRTT is set to report its fiscal Q2 on Tuesday, July 30, after market close, with the conference call the following day at 10 am.

Johnston says she is looking for quarterly revenue of $90.4 million, which would represent a 12-per-cent year-over-year increase and is in line with the consensus.

 

DIRTT Environmental keeps “Buy” rating at Laurentian…

 

The analyst sees the top line growth to be led by an increase in DIRTT’s US segment as well as an FX translation tailwind, while at the same time noting that the company remains underpenetrated in major markets in the US and Canada.

On adjusted EBITDA, Johnston is calling for $9.4 million, representing a margin of 10.4 per cent and a slight improvement year-over-year.

“On the conference call, we will be looking for: (1) Update on the tile warping issue and potential long term solutions, as well as guidance as to any additional costs anticipated in H2/19; (2) Further insight into the timing of the US listing and release of the long-term strategy; and (3) Commentary on key sales vertical and outlook for growth (i.e., Healthcare, Government),” writes Johnston in an equity research update to clients on Wednesday.

The analyst says DIRTT is currently trading at 10.3x forward EV/EBITDA which compares to its office furnishings and building materials peers at 8x and 8.5x, respectively.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: drt
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

7 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

9 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

10 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

11 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 days ago